BRPI0807981A2 - Heparinas de baixo peso molecular, compreendendo pelo menos uma ligação covalente com a biotina ou um derivado da biotina, o respectivo processo de preparo e o respectivo uso - Google Patents

Heparinas de baixo peso molecular, compreendendo pelo menos uma ligação covalente com a biotina ou um derivado da biotina, o respectivo processo de preparo e o respectivo uso

Info

Publication number
BRPI0807981A2
BRPI0807981A2 BRPI0807981-1A2A BRPI0807981A BRPI0807981A2 BR PI0807981 A2 BRPI0807981 A2 BR PI0807981A2 BR PI0807981 A BRPI0807981 A BR PI0807981A BR PI0807981 A2 BRPI0807981 A2 BR PI0807981A2
Authority
BR
Brazil
Prior art keywords
biotine
biotin
derivative
understanding
molecular weight
Prior art date
Application number
BRPI0807981-1A2A
Other languages
English (en)
Inventor
Philippe Hubert
Pierre Mourier
Christian Viskov
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of BRPI0807981A2 publication Critical patent/BRPI0807981A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BRPI0807981-1A2A 2007-02-14 2008-02-12 Heparinas de baixo peso molecular, compreendendo pelo menos uma ligação covalente com a biotina ou um derivado da biotina, o respectivo processo de preparo e o respectivo uso BRPI0807981A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0701055A FR2912409B1 (fr) 2007-02-14 2007-02-14 Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
PCT/FR2008/000173 WO2008113919A1 (fr) 2007-02-14 2008-02-12 Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine, leur procede de preparation et leur utilisation

Publications (1)

Publication Number Publication Date
BRPI0807981A2 true BRPI0807981A2 (pt) 2014-06-24

Family

ID=38461986

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0807981-1A2A BRPI0807981A2 (pt) 2007-02-14 2008-02-12 Heparinas de baixo peso molecular, compreendendo pelo menos uma ligação covalente com a biotina ou um derivado da biotina, o respectivo processo de preparo e o respectivo uso

Country Status (15)

Country Link
US (1) US20100081629A1 (pt)
EP (1) EP2121769A1 (pt)
JP (1) JP5351770B2 (pt)
KR (1) KR20090109104A (pt)
CN (1) CN101636417A (pt)
AR (1) AR065323A1 (pt)
AU (1) AU2008228162A1 (pt)
BR (1) BRPI0807981A2 (pt)
CA (1) CA2678168A1 (pt)
FR (1) FR2912409B1 (pt)
IL (1) IL200111A0 (pt)
MX (1) MX2009008752A (pt)
RU (1) RU2009134188A (pt)
TW (1) TW200846014A (pt)
WO (1) WO2008113919A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008314505C1 (en) 2007-10-16 2020-11-05 Progen Pg500 Series Pty Ltd Novel sulfated oligosaccharide derivatives
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US9351992B2 (en) 2007-11-02 2016-05-31 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
JP5982361B2 (ja) 2010-04-16 2016-08-31 モメンタ ファーマシューティカルズ インコーポレイテッド 組織標的化方法
WO2011159770A2 (en) 2010-06-17 2011-12-22 Momenta Pharmaceuticals, Inc. Methods and compositions for modulating hair growth
US10016449B2 (en) 2013-05-28 2018-07-10 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
CN103421128B (zh) * 2013-07-31 2015-08-12 山东辰中生物制药有限公司 一种高品质低分子帕那肝素的制备方法
EP3388439A1 (en) * 2017-04-11 2018-10-17 Leadiant Biosciences SA Biotin-conjugated n-acetyl glycol split heparin
CN111333664A (zh) * 2020-03-27 2020-06-26 苏州昊帆生物股份有限公司 生物素交联剂、应用及其制备方法
CN117777216A (zh) * 2022-09-21 2024-03-29 中国科学院上海药物研究所 可中和的生物素化肝素五糖的制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38743E1 (en) * 1990-06-26 2005-06-14 Aventis Pharma S.A. Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
FR2663639B1 (fr) * 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
US20040229778A1 (en) * 2003-05-13 2004-11-18 Elmaleh David R. Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
FR2874924B1 (fr) * 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique

Also Published As

Publication number Publication date
JP2010518238A (ja) 2010-05-27
WO2008113919A1 (fr) 2008-09-25
AU2008228162A1 (en) 2008-09-25
MX2009008752A (es) 2009-08-27
CN101636417A (zh) 2010-01-27
EP2121769A1 (fr) 2009-11-25
JP5351770B2 (ja) 2013-11-27
CA2678168A1 (fr) 2008-09-25
IL200111A0 (en) 2010-04-15
TW200846014A (en) 2008-12-01
US20100081629A1 (en) 2010-04-01
FR2912409A1 (fr) 2008-08-15
RU2009134188A (ru) 2011-03-20
KR20090109104A (ko) 2009-10-19
FR2912409B1 (fr) 2012-08-24
AR065323A1 (es) 2009-05-27

Similar Documents

Publication Publication Date Title
BRPI0807981A2 (pt) Heparinas de baixo peso molecular, compreendendo pelo menos uma ligação covalente com a biotina ou um derivado da biotina, o respectivo processo de preparo e o respectivo uso
BRPI0813370A2 (pt) Fita de polietileno não fibroso, de peso molecular ultra-elevado e altamente orientado, e, processo para produzir uma fita de polietileno não fibroso, de peso molecular ultra-elevado e altamente orientado.
BRPI0812819A2 (pt) Artigos de fumar com características de propensão de ignição reduzida
BRPI1007325A2 (pt) "baixo peso molecular de polissulfatados derivados de ácido hialurônico e medicamentos que contenham o mesmo."
BRPI0722088A2 (pt) derivados de pirrolo[2,3-b]piridina como moduladores de cinase
IL202039A0 (en) Florene, anthracene, xanthene, dibenzosuberone and acridine derivatives, compositions comprising the same and uses thereof
BRPI0817265A2 (pt) Vacina de rna, uso de pelo menos uma molécula de rna, e, molécula de rna isolada
BRPI0819048A2 (pt) "mantas de eletreto com aditivos acentuadores de carga"
BRPI0813709A2 (pt) Derivados de nucleosídeo substituído com propriedades antiviral e antimicrobiana
DK1948561T3 (da) Multi-substitueret hydroxyapatit og sammensætning deraf med en naturlig og/eller syntetisk polymer, fremstilling og anvendelser deraf
BRPI0716175A2 (pt) Artigos absorventes compreendendo polímeros superabsorventes com propriedades superiores.
BRPI0811621A2 (pt) Oligonucleotídeos de classe a com potência imunoestimuladora, composição contendo os mesmos e uso da referida composição
BRPI0818941A2 (pt) "planta, métodos de alteração da arquitetura de raízes em plantas, de avaliação da arquitetura de raízes em plantas, de determinação de alteração de uma característica agronômica em uma planta, de transformação de células, de produção de plantas, polinucleotídeo, vetor e reconstrução de dna recombinante"
WO2010023670A3 (en) Methods for covalently attaching a polymer to a methionine residue in proteins and peptides
BRPI0811933A2 (pt) Avaliação da proporção de gás-óleo sa partir de outras propriedades físicas
WO2009105042A8 (en) Thienothiophene derivatives
FR2932450B1 (fr) Cale de liaison rapide
IL198648A (en) History of triazindione as gaba – b receptor modulators, pharmaceutical preparations containing them and their use
SI2066679T1 (sl) Konjugati disorazolov in njihovi derivati z molekulami, ki vežejo celice, novi disorazolni derivati, postopki za njihovo izdelavo in njihova uporaba
IL199880A0 (en) Heparins including at least one covalent bond with biotin or a biotin derivative, method for preparing same and use thereof
FR2922885B1 (fr) Fils de verre a faible teneur en alumine aptes a renforcer des matieres organiques et/ou inorganiques.
WO2008107912A3 (en) In vitro assay methods for classifying embryotoxicity of compounds
BRPI0921732A2 (pt) processo para a preparação de "telechelen" com ampla distribuição de peso molecular
DE602007010427D1 (de) Antibiotische ethanol- oder 1,2-ethandiol-cyclohexyl-derivate
CY1110787T1 (el) Νεα μορφινικα παραγωγα

Legal Events

Date Code Title Description
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 5A E 6A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A, 8A, 9A, 10A, 11A E 12A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.